ZARRILLI STEPHEN T 4

What Happened Stephen T. Zarrilli, a director of Globus Medical, received a grant of 15,000 derivative securities reported as acquired at $0.00 on January 21, 2026. The Form 4 lists the transaction as an award/grant (code A); the filing reports $0 total value at acquisition. This was an equity award (likely stock options or restricted stock units), not an open-market purchase or sale.

Key Details

• Transaction date: January 21, 2026; Form 4 filed January 23, 2026 (filed timely, within the typical two-business-day window).
• Transaction type: A = Grant/Award (derivative securities).
• Quantity: 15,000 derivative shares; reported acquisition price $0.00; reported value $0.
• Vesting: Per footnote, the options were granted on Jan 21, 2026 and will vest on Jan 1, 2027.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 confirms grant date and vesting schedule.
• No immediate sale or exercise was reported in this filing.

Context This is a compensation-related award, not a cash purchase or sale. Because the grant vests on Jan 1, 2027, the securities generally cannot be realized until vesting (subject to plan rules). Awards like this are commonly part of director/executive pay and do not by themselves indicate a buying or selling signal.